InvestorsHub Logo

ilovetech

12/14/22 6:52 PM

#395679 RE: IgnoranceIsBliss #395668

It sure looks that way.

Tatsumaki

12/14/22 6:58 PM

#395681 RE: IgnoranceIsBliss #395668

>new indications
Nobody's gonna drop huge cash on a Alz clinical big enough to get a FDA approval for a ubiquitous molecule with 0 market exclusivity. EPA is done. All that's left is whatever Amarin can scape out of the EU market for the next 7 years and that's not looking good.

shadolane

12/14/22 7:15 PM

#395683 RE: IgnoranceIsBliss #395668

As it turns out you are exactly right.

The management group has become enriched in spite of their performance and in spite of the stock price.

They have no incentive to change anything.

At this point I would say there is not much that could be done anyway to salvage this listing ship.

The EU looks to be like dominoes. Others may follow suit based on similar reasoning.